Andreeff M , Drach J, Sanchez-Williams G, Zhao S, Liu S, Kornblau S, Escudier S, Kantarjian H, Deisseroth A, Estey E
99 Until more robust trials confirm their safety specifically in patients with reduced LVEF, GLP-1 RAs should be used cautiously in this population
This discrepancy may be due to the length of the dexamethasone administration period
This decision was based on the results of the SELECT trial, which followed over 17,600 participants and found that Wegovy reduced the risk of major adverse cardiovascular events by about 20%
GLP-1 injections and the Wegovy pill contain a precisely measured, FDA-approved dose
This is different from medications like phentermine, which may cause increased heart rate, insomnia, or elevated blood pressure